Year : 2012  |  Volume : 3  |  Issue : 2  |  Page : 98-104

Pharmacotherapy for multidrug resistant tuberculosis

1 Department of Pharmacology, J. L. N. Medical College, Ajmer, Rajasthan, India
2 Department of Respiratory Medicine, J. L. N. Medical College, Ajmer, Rajasthan, India

Correspondence Address:
Naveen Chhabra
Department of Pharmacology, J. L. N. Medical College, Ajmer, Rajasthan
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0976-500X.95502

Rights and Permissions

The current global concern in the treatment of tuberculosis (TB) is the emergence of resistance to the two most potent drugs namely, isoniazid and rifampicin. Emergence of multidrug resistance tuberculosis (MDR-TB) is now a health problem faced by most of the developing countries as well as developed countries across the globe. MDR-TB is a man-made disease that is caused by improper treatment, inadequate drug supplies, and poor patient supervision. HIV infection and AIDS have been implicated as important cause for this. The review of a published literature suggests that the most powerful predictor of treatment of MDR-TB is a history of treatment of TB. Although the treatment is efficacious, there are also a number of adverse effects caused by drugs used in the treatment of MDR-TB.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1223    
    Comments [Add]    
    Cited by others 1    

Recommend this journal